Original Research
26 May 2020

Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy

Publication: Annals of Internal Medicine
Volume 173, Number 2
Visual Abstract. Long-Term CRC Incidence and Mortality After Negative Screening Colonoscopy The current colorectal cancer (CRC) screening guidelines recommend colonoscopy every 10 years for an average-risk population. However, this recommendation is based on limited, indirect evidence. This study aimed to quantify the long-term risk for CRC incidence and mortality after a single negative result on screening colonoscopy. It also evaluated the associations between the quality of the baseline colonoscopy and the subsequent risk for CRC incidence and mortality.
Visual Abstract. Long-Term CRC Incidence and Mortality After Negative Screening Colonoscopy
The current colorectal cancer (CRC) screening guidelines recommend colonoscopy every 10 years for an average-risk population. However, this recommendation is based on limited, indirect evidence. This study aimed to quantify the long-term risk for CRC incidence and mortality after a single negative result on screening colonoscopy. It also evaluated the associations between the quality of the baseline colonoscopy and the subsequent risk for CRC incidence and mortality.

Abstract

Background:

Current guidelines recommend a 10-year interval between screening colonoscopies, but evidence is limited.

Objective:

To assess the long-term risk for colorectal cancer (CRC) and death from CRC after a high- and low-quality single negative screening colonoscopy.

Design:

Observational study.

Setting:

Polish Colonoscopy Screening Program.

Participants:

Average-risk individuals aged 50 to 66 years who had a single negative colonoscopy (no neoplastic findings).

Measurements:

Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) of CRC after high- and low-quality single negative screening colonoscopy. High-quality colonoscopy included a complete examination, with adequate bowel preparation, performed by endoscopists with an adenoma detection rate of 20% or greater.

Results:

Among 165 887 individuals followed for up to 17.4 years, CRC incidence (0.28 [95% CI, 0.25 to 0.30]) and mortality (0.19 [CI, 0.16 to 0.21]) were 72% and 81% lower, respectively, than in the general population. High-quality examination resulted in 2-fold lower CRC incidence (SIR, 0.16 [CI, 0.13 to 0.20]) and mortality (SMR, 0.10 [CI, 0.06 to 0.14]) than low-quality examination (SIR, 0.32 [CI, 0.29 to 0.35]; SMR, 0.22 [CI, 0.18 to 0.25]). In multivariable analysis, the hazard ratios for CRC incidence after high-quality versus low-quality colonoscopy were 0.55 (CI, 0.35 to 0.86) for 0 to 5 years, 0.54 (CI, 0.38 to 0.77) for 5.1 to 10 years, and 0.46 (CI, 0.25 to 0.86) for 10 to 17.4 years. Only after high-quality colonoscopy did the SIR and SMR for 10.1 to 17.4 years of follow-up not differ compared with earlier observation periods.

Limitation:

The general population was used as the comparison group.

Conclusion:

A single negative screening colonoscopy was associated with reduced CRC incidence and mortality for up to 17.4 years. Only high-quality colonoscopy yielded profound and stable reductions in CRC incidence and mortality throughout the entire follow-up.

Primary Funding Source:

Polish Ministry of Health.

Get full access to this article

View all available purchase options and get full access to this article.

Supplemental Material

Supplement. Supplementary Material.

References

1.
Wolf AMDFontham ETHChurch TRet al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250-281. [PMID: 29846947]  doi: 10.3322/caac.21457
2.
Rex DKBoland CRDominitz JAet al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153:307-323. [PMID: 28600072]  doi: 10.1053/j.gastro.2017.05.013
3.
von Karsa LPatnick JSegnan Net alEuropean Colorectal Cancer Screening Guidelines Working Group. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45:51-9. [PMID: 23212726]  doi: 10.1055/s-0032-1325997
4.
Winawer SJFletcher RHMiller Let al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642. [PMID: 9024315]
5.
Brenner HChang-Claude JSeiler CMet al. Does a negative screening colonoscopy ever need to be repeated? Gut. 2006;55:1145-50. [PMID: 16469791]
6.
Lakoff JPaszat LFSaskin Ret al. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol. 2008;6:1117-21; quiz 1064. [PMID: 18691942]  doi: 10.1016/j.cgh.2008.05.016
7.
Nishihara RWu KLochhead Pet al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095-105. [PMID: 24047059]  doi: 10.1056/NEJMoa1301969
8.
Lee JKJensen CDLevin TRet al. Long-term risk of colorectal cancer and related deaths after a colonoscopy with normal findings. JAMA Intern Med. 2019;179:153-160. [PMID: 30556824]  doi: 10.1001/jamainternmed.2018.5565
9.
Rex DKSchoenfeld PSCohen Jet al. Quality indicators for colonoscopy. Am J Gastroenterol. 2015;110:72-90. [PMID: 25448873]  doi: 10.1038/ajg.2014.385
10.
Kaminski MFRegula JKraszewska Eet al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362:1795-803. [PMID: 20463339]  doi: 10.1056/NEJMoa0907667
11.
Atkin WWooldrage KParkin DMet al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet. 2017;389:1299-1311. [PMID: 28236467]  doi: 10.1016/S0140-6736(17)30396-3
12.
Segnan NArmaroli PBonelli Let alSCORE Working Group. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial—SCORE. J Natl Cancer Inst. 2011;103:1310-22. [PMID: 21852264]  doi: 10.1093/jnci/djr284
13.
Holme ØLøberg MKalager Met al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014;312:606-15. [PMID: 25117129]  doi: 10.1001/jama.2014.8266
14.
Baxter NNWarren JLBarrett MJet al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol. 2012;30:2664-9. [PMID: 22689809]  doi: 10.1200/JCO.2011.40.4772
15.
Brenner HChang-Claude JSeiler CMet al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154:22-30. [PMID: 21200035].  doi: 10.7326/0003-4819-154-1-201101040-00004
16.
Regula JRupinski MKraszewska Eet al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863-72. [PMID: 17079760]
17.
Lieberman DNadel MSmith RAet al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007;65:757-66. [PMID: 17466195]
18.
Aronchick CALipshutz WHWright SHet al. Validation of an instrument to assess colon cleansing [Abstract]. Am J Gastroenterol. 1999;94:2667.
19.
Rex DKPetrini JLBaron THet alASGE/ACG Taskforce on Quality in Endoscopy. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101:873-85. [PMID: 16635231]
20.
Didkowska JWojciechowska U. Cancer in Poland in 2013. Warsaw: National Cancer Registry of Poland, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology; 2015.
21.
Ederer FMantel N. Confidence limits on the ratio of two Poisson variables. Am J Epidemiol. 1974;100:165-7. [PMID: 4412586]
22.
Breslow NEDay NE. Statistical Methods in Cancer Research. Lyon, France: International Agency for Research on Cancer, World Health Organization; 1987.
23.
Statistics Poland. 2019. Accessed at https://bdl.stat.gov.pl/BDL/start on 6 November 2019.
24.
Baxter NNGoldwasser MAPaszat LFet al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1-8. [PMID: 19075198]
25.
Holme ØLøberg MKalager Met alNORCCAP Study Group. Long-term effectiveness of sigmoidoscopy screening on colorectal cancer incidence and mortality in women and men: a randomized trial. Ann Intern Med. 2018;168:775-782. [PMID: 29710125].  doi: 10.7326/M17-1441
26.
Zauber AGWinawer SJO'Brien MJet al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687-96. [PMID: 22356322]  doi: 10.1056/NEJMoa1100370
27.
Lieberman DAHolub JLMorris CDet al. Low rate of large polyps (>9 mm) within 10 years after an adequate baseline colonoscopy with no polyps. Gastroenterology. 2014;147:343-50. [PMID: 24768680]  doi: 10.1053/j.gastro.2014.04.020
28.
Ponugoti PLRex DK. Yield of a second screening colonoscopy 10 years after an initial negative examination in average-risk individuals. Gastrointest Endosc. 2017;85:221-224. [PMID: 27222282]  doi: 10.1016/j.gie.2016.05.024
29.
Murthy SKDubé CRostom Aet al. Risk of colorectal cancer after a negative colonoscopy in low-to-moderate risk individuals: impact of a 10-year colonoscopy. Endoscopy. 2017;49:1229-1236. [PMID: 28915524]  doi: 10.1055/s-0043-117402
30.
Zauber AGLansdorp-Vogelaar IKnudsen ABet al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:659-69. [PMID: 18838717]
31.
Knudsen ABZauber AGRutter CMet al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA. 2016;315:2595-609. [PMID: 27305518]  doi: 10.1001/jama.2016.6828
32.
Helsingen LMVandvik POJodal HCet al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019;367:l5515. [PMID: 31578196]  doi: 10.1136/bmj.l5515
33.
Robertson DJLieberman DAWinawer SJet al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014;63:949-56. [PMID: 23793224]  doi: 10.1136/gutjnl-2012-303796
34.
Kaminski MFRegula JKraszewska Eet al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362:1795-803. [PMID: 20463339]  doi: 10.1056/NEJMoa0907667
35.
Corley DAJensen CDMarks ARet al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298-306. [PMID: 24693890]  doi: 10.1056/NEJMoa1309086
36.
Kaminski MFThomas-Gibson SBugajski Met al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2017;49:378-397. [PMID: 28268235]  doi: 10.1055/s-0043-103411
37.
Rondagh EJBouwens MWRiedl RGet al. Endoscopic appearance of proximal colorectal neoplasms and potential implications for colonoscopy in cancer prevention. Gastrointest Endosc. 2012;75:1218-25. [PMID: 22482917]  doi: 10.1016/j.gie.2012.02.010
38.
IJspeert JEBastiaansen BAvan Leerdam MEDutch Workgroup serrAted polypS & Polyposis (WASP). Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps. Gut. 2016;65:963-70. [PMID: 25753029]  doi: 10.1136/gutjnl-2014-308411
39.
Kahi CJLi XEckert GJet al. High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. Gastrointest Endosc. 2012;75:515-20. [PMID: 22018551]  doi: 10.1016/j.gie.2011.08.021
40.
Brenner HStock CHoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467. [PMID: 24922745]  doi: 10.1136/bmj.g2467
41.
Kaminski MFWieszczy PRupinski Met al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology. 2017;153:98-105. [PMID: 28428142]  doi: 10.1053/j.gastro.2017.04.006

Comments

0 Comments
Sign In to Submit A Comment

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 173Number 221 July 2020
Pages: 81 - 91

History

Published online: 26 May 2020
Published in issue: 21 July 2020

Keywords

Authors

Affiliations

Nastazja Dagny Pilonis, MD
The Maria Sklodowska-Curie National Research Institute of Oncology and Medical Center for Postgraduate Education, Warsaw, Poland (N.D.P., M.B., P.W., M.R., J.R.)
Marek Bugajski, MD, PhD
The Maria Sklodowska-Curie National Research Institute of Oncology and Medical Center for Postgraduate Education, Warsaw, Poland (N.D.P., M.B., P.W., M.R., J.R.)
Paulina Wieszczy, MSc
The Maria Sklodowska-Curie National Research Institute of Oncology and Medical Center for Postgraduate Education, Warsaw, Poland (N.D.P., M.B., P.W., M.R., J.R.)
Robert Franczyk, MD
The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (R.F., M.P.)
Joanna Didkowska, PhD
National Cancer Registry of Poland, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (J.D., U.W.)
Urszula Wojciechowska, PhD
National Cancer Registry of Poland, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (J.D., U.W.)
Malgorzata Pisera, PhD
The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (R.F., M.P.)
Maciej Rupinski, MD, PhD
The Maria Sklodowska-Curie National Research Institute of Oncology and Medical Center for Postgraduate Education, Warsaw, Poland (N.D.P., M.B., P.W., M.R., J.R.)
Jaroslaw Regula, MD, PhD
The Maria Sklodowska-Curie National Research Institute of Oncology and Medical Center for Postgraduate Education, Warsaw, Poland (N.D.P., M.B., P.W., M.R., J.R.)
Michal Filip Kaminski, MD, PhD
The Maria Sklodowska-Curie National Research Institute of Oncology and Medical Center for Postgraduate Education, Warsaw, Poland, and Institute of Health and Society, University of Oslo, Oslo, Norway (M.F.K.)
Financial Support: By the Polish Ministry of Health, the Medical Center for Postgraduate Education in Warsaw (grant 5011091217/18), and the Polish Foundation of Gastroenterology.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Reproducible Research Statement: Study protocol and statistical code: Available from Dr. Pilonis (e-mail, [email protected]). Data set: Not available.
Corresponding Author: Nastazja Dagny Pilonis, MD, Department of Gastroenterology, The Maria Sklodowska-Curie National Research Institute of Oncology, Roentgen Street 5, 02-781 Warsaw, Poland; e-mail, [email protected].
Current Author Addresses: Drs. Pilonis, Bugajski, Franczyk, Rupinski, and Regula: Department of Gastroenterology, The Maria Sklodowska-Curie National Research Institute of Oncology, Roentgen Street 5, 02-781 Warsaw, Poland.
Drs. Wieszczy, Pisera, and Kaminski: Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, The Maria Sklodowska-Curie National Research Institute of Oncology, Roentgen Street 5, 02-781 Warsaw, Poland.
Drs. Didkowska and Wojciechowska: National Cancer Registry of Poland, The Maria Sklodowska-Curie National Research Institute of Oncology, Wawelska Street 15B, 02-034 Warsaw, Poland.
Author Contributions: Conception and design: N.D. Pilonis, M. Bugajski, P. Wieszczy, M.F. Kaminski.
Analysis and interpretation of the data: N.D. Pilonis, M. Bugajski, P. Wieszczy, R. Franczyk, M. Rupinski, J. Regula, M.F. Kaminski.
Drafting of the article: N.D. Pilonis, R. Franczyk, M. Rupinski, J. Regula.
Critical revision for important intellectual content: N.D. Pilonis, M. Bugajski, P. Wieszczy, J. Didkowska, U. Wojciechowska, M.F. Kaminski, J. Regula,
Final approval of the article: N.D. Pilonis, M. Bugajski, P. Wieszczy, R. Franczyk, J. Didkowska, U. Wojciechowska, M. Pisera, M. Rupinski, J. Regula, M.F. Kaminski.
Provision of study materials or patients: M. Rupinski, M.F. Kaminski.
Statistical expertise: P. Wieszczy.
Obtaining of funding: M.F. Kaminski.
Administrative, technical, or logistic support: M. Rupinski, J. Regula.
Collection and assembly of data: N.D. Pilonis, R. Franczyk, J. Didkowska, U. Wojciechowska, M. Rupinski, J. Regula, M.F. Kaminski.
This article was published at Annals.org on 26 May 2020.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Nastazja Dagny Pilonis, Marek Bugajski, Paulina Wieszczy, et al. Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy. Ann Intern Med.2020;173:81-91. [Epub 26 May 2020]. doi:10.7326/M19-2477

View More

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/EPUB

View PDF/EPUB

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media